Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
J Pak Med Assoc ; 74(2): 400-401, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38419247

RESUMO

In this communication, we define and describe gut guardianship as the processes, behaviours and activities that may be followed or undertaken, so as to achieve and maintain a healthy gut, and gut microbiome. These include aspects such related to nutrition, lifestyle, rational drug use, and microbial modulation by using prebiotics and probiotics. Gut guardianship helps in optimizing various aspects of human health including metabolic health, mitogenic balance, micronutrient absorption, mood (gaity) maintenance, gut immunity, and general well-being.


Assuntos
Microbioma Gastrointestinal , Probióticos , Humanos , Prebióticos , Probióticos/uso terapêutico , Estado Nutricional , Nível de Saúde
2.
Cureus ; 16(1): e51669, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38313989

RESUMO

Pain relief is an integral component of any orthodontic procedure given its high association with patient compliance and treatment adherence. A transdermal drug delivery system (TDDS) is a non-invasive method of drug delivery through the skin surface that can spread the medication throughout the dermis at a predetermined rate to produce a local or systemic effect. It might be used in place of hypodermic injections and the oral medication route. A transdermal analgesic, often known as a pain reliever patch, is an adhesive patch that contains medication to treat mild-to-severe pain. Many opioids and non-steroidal anti-inflammatory drugs are currently available as patches. TDDS offers many benefits over the conventional medication delivery method. The non-invasive transdermal route or therapy has features such as excellent bioavailability, stable medication plasma concentration, and no first-pass metabolism effect. This review aims to explore the available evidence on the use of transdermal patches for pain relief in orthodontic procedures and possibly suggest recommendations based on the findings.

3.
J Pak Med Assoc ; 73(11): 2286-2287, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38013550

RESUMO

Diabetes is associated with a myriad of mental health challenges, ranging from distress and depression to schizophrenia and substance abuse. These conditions are associated with hyperglycaemia, and also interfere with efforts to achieve good glucose control. One way in which this can be handled is by screening, early diagnosis, and timely management of mental health dysfunction and disorders. We term this action as psychovigilance.


Assuntos
Diabetes Mellitus , Hiperglicemia , Transtornos Relacionados ao Uso de Substâncias , Humanos , Depressão/psicologia , Diabetes Mellitus/epidemiologia , Saúde Mental , Ansiedade/psicologia
4.
J Pak Med Assoc ; 73(2): 426-427, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36800745

RESUMO

Water is ubiquitous in nature, and that is why, perhaps, it is not viewed as a nutrient. In the context of diabetes, water intake may have implications in increasing insulin resistance, development of complications, relation to anti-diabetic agents and also in prevention of diabetes. In this brief article, we list various aspects of water nutrition, i.e., hydration that support its status as a mega- nutrient, as a preventative therapy against diabetes, and as a treatment modality for diabetes and its complications.


Assuntos
Diabetes Mellitus , Resistência à Insulina , Humanos , Água , Diabetes Mellitus/prevenção & controle , Hipoglicemiantes/uso terapêutico
5.
J Assoc Physicians India ; 71(12): 28-31, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38736051

RESUMO

OBJECTIVE: To understand the national pattern of proton-pump inhibitor (PPI) prescriptions and to disseminate evidence-based recommendations for using probiotics as an adjunct to PPIs across diverse clinical indications. METHODS: Healthcare professionals' (HCPs) inputs and views were collected through a survey (n = 1,007) and four round table meetings (RTMs, n = 4). A standardized questionnaire focusing on the utilization of PPIs in clinical practice was developed, deliberated upon, and assessed by experts specializing in the treatment of diverse acid-related gastrointestinal (GI) conditions across various geographical regions. RESULTS: Of the total 1,007 contributors, most (43.40%) opined that 10-30% of their patients were prescribed PPI for a long duration. The majority of contributors commonly prescribed PPIs for the prophylaxis of gastroesophageal reflux disease (GERD)-induced gastritis (70.90%), peptic ulcer disease (58.39%), and various GI conditions. The majority of contributors (91%) agreed or strongly agreed that long-term use of PPIs disturbs the GI flora. Antibiotic-associated diarrhea (AAD) (78.05%) was the most preferred indication for using pre- and probiotics. The duration for co-prescription varied, with a substantial portion advocating for 1-4 weeks (49.65%), while others supported durations of 4-8 weeks or beyond. Around 85% of contributors/HCPs agreed or strongly agreed on prescribing pre- and probiotics as prophylaxis to prevent GI disturbances. The study emphasized the growing trend of patient-centered co-prescription of PPIs and pre-/probiotics, with a majority of contributors favoring this approach. CONCLUSION: The results underscore the importance of informed prescribing practices, including the co-prescription of probiotics, to mitigate potential side effects associated with long-term PPI use and optimize patient well-being.


Assuntos
Padrões de Prática Médica , Probióticos , Inibidores da Bomba de Prótons , Inibidores da Bomba de Prótons/administração & dosagem , Probióticos/administração & dosagem , Probióticos/uso terapêutico , Humanos , Padrões de Prática Médica/estatística & dados numéricos , Quimioterapia Combinada , Inquéritos e Questionários , Gastroenteropatias/prevenção & controle , Gastroenteropatias/induzido quimicamente , Refluxo Gastroesofágico/tratamento farmacológico
6.
J Pak Med Assoc ; 72(12): 2565-2566, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37246693

RESUMO

Adult vaccination is an accepted part of health care and diabetes care. In spite of evidence regarding the efficacy and utility of vaccination in preventing disease, we continue to encounter vaccine hesitancy and vaccine skepticism. As physicians, it is our duty to encourage the public to get vaccinated. In this article, we create a simple framework which helps assess the barriers to vaccine acceptance, and create bridges to overcome vaccine hesitancy and skepticism. We use an interesting mnemonic, NARCO, to remind ourselves, and our readers, of the appropriate hierarchy of interviewing related to vaccine acceptance.


Assuntos
Médicos , Hesitação Vacinal , Adulto , Humanos , Instalações de Saúde , Memória , Vacinação , Atenção Primária à Saúde
7.
J Pak Med Assoc ; 72(11): 2335-2336, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37013319

RESUMO

This communication describes the concept of human centred diabetes care. It makes a distinction between patient centred and person centred care on one hand, and human centred care on the other. Human centred diabetes care is a grounded concept, which encompasses the philosophy of patient centred care, and blends it with a humanistic approach to management. It encourages the health care provider to view the person, living with diabetes, as a human being, and as part of a family, community and society. It also reminds the provider about his or her strengths and shortcomings, both of which are part of being human, and encourages him or her to strive towards becoming a better diabetes care provider, as well as human being. The human care model is relevant to all health delivery, and especially to chronic care such as diabetes management.


Assuntos
Diabetes Mellitus , Humanos , Masculino , Feminino , Diabetes Mellitus/terapia , Pessoal de Saúde , Assistência Centrada no Paciente , Comunicação
8.
J Pak Med Assoc ; 72(11): 2337-2338, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37013320

RESUMO

A recent increase in the prevalence of obesity has been noticed in individuals of all age groups. With an increase in life expectancy, more elderly people are affected with obesity 'This is often associated with low muscle mass. This entity called as sarcopenic obesity is known to be associated with a significant higher morbidity and mortality. However, due to complex definitions and techniques used to define sarcopenic obesity, it is often under diagnosed in clinical practice. In this manuscript we propose simple, cost effective and easy to use anthropometric indices based on standard south Asian cutoffs that could help in screening and diagnosis of Sarcopenic obesity.


Assuntos
Obesidade , Sarcopenia , Idoso , Humanos , Antropometria , Obesidade/complicações , Obesidade/epidemiologia , Obesidade/diagnóstico , Sarcopenia/complicações , Sarcopenia/diagnóstico , Sarcopenia/epidemiologia
9.
J Pharm Bioallied Sci ; 13(Suppl 2): S1513-S1516, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-35018020

RESUMO

INTRODUCTION: The silent killer, hypertension (HTN), is a significant risk factor for cardiovascular disease. In India, HTN has a major public health effect on cardiovascular health and health-care systems. AIM: The present study was aimed to evaluate the awareness of general practitioners (GPs) toward HTN management and also their approach toward management. MATERIALS AND METHODS: The present study was a questionnaire-based assessment study. A total of 100 GPs were included in the study as our study sample. All the participants were well informed about the study and after that those who were willing to participate were enrolled after obtaining a written informed consent. RESULTS: The common presenting symptoms of hypertensive patients were predominantly morning headache (71%), dizziness (41%), palpitation (39%), and fatigability (29%). Majority (84%) practiced cuff placement method covering about 2/3rd of the arm at heart level. The preferred position while blood pressure (BP) examination of patient by majority of practitioners was while sitting (53%). The number of readings usually taken for measuring BP for each patient was as follows: one (3%), two (42%), and three (55)%. CONCLUSION: Although GPs in our study are well informed and up to date on certain aspects of HTN diagnosis and treatment, they may still lack an appropriate approach to HTN history taking, diagnosis, and treatment.

10.
Ther Adv Endocrinol Metab ; 11: 2042018820937217, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32647562

RESUMO

OBJECTIVE: To assess the real-world management practices of subjects with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in India. METHODS: This cross-sectional study was conducted between 7 March 2016 and 15 May 2016 in India as part of the seventh wave (2016) of the International Diabetes Management Practices Study (IDMPS). Adult subjects with T1DM or T2DM visiting physicians during a 2-week recruitment period were included. RESULTS: A total of 55 physicians included 539 subjects who met eligibility criteria. Of 495 subjects with T2DM, 303 were treated with oral glucose lowering drugs (OGLDs) only, 158 were treated with OGLD + insulin, and 27 received insulin only. Among 44 subjects with T1DM receiving insulin, 13 (29.5%) were also treated with OGLD therapy. The most commonly used insulin regimens were basal alone (69/184; 37.5%) and premixed alone (63/184; 34.2%) in subjects with T2DM, and basal + prandial insulin (24/44; 54.5%) in subjects with T1DM. Proportions of subjects achieving glycemic targets were low [glycated haemoglobin (HbA1c) <7%: T1DM = 7.3% (3/44), T2DM = 25.2% (106/495); as targeted by the treating physician: T1DM = 31.8% (14/44), T2DM = 32.1% (59/185); global target: T1DM = 4.8% (2/42) and T2DM = 1.7% (8/482)]. In subjects with T2DM, HbA1c <7% was noted in 11/22 subjects receiving insulin only and 76/260 receiving only OGLDs. Lack of experience in self-managing insulin dosing, poor diabetes education and failure to titrate insulin dosages were the main reasons for non-achievement of glycemic targets. CONCLUSION: Timely insulinization, education and empowerment of people with diabetes may help improve glycemic control in India.

11.
Indian J Endocrinol Metab ; 22(4): 560-564, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30148107

RESUMO

The Shrimad Bhagavad Gita enlightens everyone on how to cope up with various situations in life. It uses the conversation between Lord Krishna and Arjuna to highlight initial negative coping mechanisms exhibited by the latter. It goes on to showcase positive coping skills suggested by Lord Krishna and implemented by Arjuna. The Bhagavad Gita, through this "case-based methodology," teaches us how to cope with a demanding situation. Diabetes is a lifestyle disease, which warrants a thorough change in one's lifestyle, including changes in basic activities such as diet and exercise. This brief communication utilizes the teachings of Bhagavad Gita to help in coping with illness, especially chronic illness such as diabetes. The article cites verses from the Bhagavad Gita to show how one may cope with the stress of illness such as diabetes.

12.
Indian J Endocrinol Metab ; 21(6): 893-897, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29285455

RESUMO

This communication presents verses from the Bhagavad Gita which help define a good clinician's skills and behavior. Using the teachings of Lord Krishna, these curated verses suggest three essential skills that a physician must possess: Excellent knowledge, equanimity, and emotional attributes. Three good behaviors are listed (Pro-work ethics, Patient-centered care, and Preceptive leadership) and supported by thoughts written in the Gita.

14.
Indian J Endocrinol Metab ; 21(1): 238-241, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28217525

RESUMO

This review describes the various fasts observed by adherents of the Jain religion. It attempts to classify them according to their suitability for people with diabetes and suggests appropriate regime and dose modification for those observing these fasts. The review is an endeavor to encourage rational and evidence-based management in this field of diabetology.

15.
Med Hypotheses ; 90: 63-5, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27063088

RESUMO

HLA-B27 is having strong association to ankylosing spondylitis (AS) and other inflammatory diseases collectively known as seronegative spondyloarthropathy. In literature, although the evidence for association between AS and periodontitis as well as AS and HLA-B27 are there but the association of aggressive periodontitis in HLA-B27 positive patient with AS are not there. We hypothesize that there may be a common pathogenesis in aggressive periodontitis and ankylosing spondylitis in HLA-B27 patient. A 27-years-old female presented with the features of generalized aggressive periodontitis and difficulty in walking. On complete medical examination, ankylosing spondylitis was diagnosed with further positive HLA-B27 phenotype and negative rheumatic factor. This report may open up a new link to explore in the pathogenesis of aggressive periodontitis.


Assuntos
Periodontite Agressiva/complicações , Antígeno HLA-B27/análise , Modelos Biológicos , Espondilite Anquilosante/complicações , Adulto , Periodontite Agressiva/diagnóstico por imagem , Periodontite Agressiva/genética , Periodontite Agressiva/imunologia , Perda do Osso Alveolar/diagnóstico por imagem , Perda do Osso Alveolar/etiologia , Feminino , Predisposição Genética para Doença , Humanos , Inflamação , Fenótipo , Espondilite Anquilosante/diagnóstico por imagem , Espondilite Anquilosante/genética , Espondilite Anquilosante/imunologia
16.
Curr Med Res Opin ; 31(11): 2105-17, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26371518

RESUMO

OBJECTIVE: To evaluate the efficacy and safety of atorvastatin + hydroxychloroquine fixed-dose combination tablets in comparison with atorvastatin alone in treatment of dyslipidemia. METHODS: This double-blind, randomized, out-patient study was conducted in 328 patients with primary dyslipidemia having low-density lipoprotein cholesterol (LDL-C) ≥ 130 mg/dL (3.37 mmol/L) to ≤ 250 mg/dL (6.48 mmol/L) and triglycerides ≤ 400 mg/dL (4.52 mmol/L). Eligible patients were randomized to receive either atorvastatin 10 mg (n = 167) or atorvastatin 10 mg + hydroxychloroquine 200 mg (n = 161) for 24 weeks. CLINICAL TRIAL REGISTRATION: CTRI/2010/091/006138. MAIN OUTCOME MEASURES: To compare percentage change in LDL-C, total cholesterol (TC), triglycerides, high-density lipoprotein cholesterol (HDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) from baseline to Week 12 and Week 24 between groups. To compare mean change in glycated hemoglobin (HbA1c), fasting blood glucose (FBG), high-sensitivity C-reactive protein (Hs-CRP), and percentage of patients achieving lipid goals at Week 12 and Week 24. RESULTS: At Week 24, percentage reduction in LDL-C (-32.52 [-36.13 to -28.91] vs -39.54 [-43.25 to -35.83]; p = 0.008), TC (-24.41 [-27.10 to -21.72] vs -29.30 [-32.07 to -26.54]; p = 0.013), and non-HDL-C (-30.37 [-33.71 to -27.04] vs -36.76 [-40.18 to -33.33]; p = 0.009) was significantly greater in combination treated patients. Both the treatments showed a significant reduction in triglycerides at Week 24 from baseline, however, this reduction was not statistically significantly different between treatment groups. No significant change in HDL-C was observed in patients from both the treatment groups. At Week 24, change in HbA1c (0.22 [0.07 to 0.37] vs -0.13 [-0.28 to 0.03]; p = 0.002) and FBG was also statistically significant in favor of combination therapy (0.37 [0.07 to 0.67] vs -0.29 [-0.59 to 0.03]; p = 0.003), whereas no statistically significant difference was observed in change in Hs-CRP (p = 0.310). Significantly more patients from the combination group achieved LDL-C and TC goals. Exploratory analysis in patients with pre-diabetes showed development of diabetes in 8 patients (15.09%) from the monotherapy group and 1 patient (1.96%) from the combination group (p = 0.034). Study medications were generally safe and well tolerated. CONCLUSION: Based on study results and widely reported pleiotropic benefits, hydroxychloroquine could emerge as a potential drug for combination with statins for treatment of dyslipidemia. Long duration studies with larger sample sizes are required to further explore the role of hydroxychloroquine as adjunct to statins in reducing risk of cardiovascular events and prevention of statin-induced diabetes.


Assuntos
Atorvastatina/administração & dosagem , Dislipidemias/tratamento farmacológico , Hidroxicloroquina/administração & dosagem , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Adulto , Anticolesterolemiantes/administração & dosagem , Anticolesterolemiantes/uso terapêutico , Atorvastatina/uso terapêutico , Proteína C-Reativa/metabolismo , Colesterol/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Método Duplo-Cego , Combinação de Medicamentos , Feminino , Hemoglobinas Glicadas/metabolismo , Humanos , Hidroxicloroquina/uso terapêutico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Triglicerídeos/sangue
18.
Indian J Endocrinol Metab ; 19(2): 198-203, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25729681

RESUMO

This communication is the first of a series on South Asian fasts, festivals, and diabetes, designed to spread awareness and stimulate research on this aspect of diabetes and metabolic care. It describes the various fasts observed as part of Hindu religion and offers a classification scheme for them, labeling them as infrequent and frequent. The infrequent fasts are further sub-classified as brief and prolonged, to facilitate a scientific approach to glycemic management during these fasts. Pre-fast counseling, non-pharmacological therapy, pharmacological modification, and post-fast debriefing are discussed in detail. All available drug classes and molecules are covered in this article, which provides guidance about necessary changes in dosage and timing of administration. While in no way exhaustive, the brief review offers a basic framework which diabetes care professionals can use to counsel and manage persons in their care who wish to observe various Hindu fasts.

20.
Curr Med Res Opin ; 30(7): 1257-66, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24669876

RESUMO

OBJECTIVE: To compare efficacy and safety of hydroxychloroquine with pioglitazone in type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: This double-blind study randomized 267 uncontrolled type 2 diabetes patients (HbA1c ≥7.5% and ≤11.5%), post 3 months' treatment with glimepiride/gliclazide and metformin, to additionally receive hydroxychloroquine 400 mg/day (n = 135) or pioglitazone 15 mg/day (n = 132) for 24 weeks. Efficacy was assessed by changes in HbA1c, fasting (FBG) and post-prandial (PPG) blood glucose at Week 12 and Week 24. RESULTS: At Week 12 and Week 24, HbA1c, FBG and PPG significantly reduced from baseline in both groups. Mean reduction in glycemic parameters at Week 12 (HbA1c: -0.56% vs -0.72%, p = 0.394; FBG: -0.99 mmol/L vs -1.05 mmol/L, p = 0.878; PPG: -1.93 mmol/L vs -1.52 mmol/L, p = 0.423) and Week 24 (HbA1c: -0.87% vs -0.90%, p = 0.909; FBG: -0.79 mmol/L vs -1.02 mmol/L, p = 0.648; PPG: -1.77 mmol/L vs -1.36 mmol/L, p = 0.415) was not significantly different between the hydroxychloroquine and pioglitazone groups. Change in total cholesterol (TC) and LDL-C was significant in favor of hydroxychloroquine (TC: -0.37 mmol/L vs 0.03 mmol/L, p = 0.002; LDL-C: -0.23 mmol/L vs 0.09 mmol/L, p = 0.003). Triglycerides significantly reduced in both groups at Week 24. Mean HDL-C remained unchanged. Study treatments were well tolerated. CONCLUSION: With favorable effects on glycemic parameters and lipids, hydroxychloroquine may emerge as well tolerated therapeutic option for T2DM. LIMITATIONS: The sample size for this study was small. However, based on the encouraging results of this proof-of-concept study, longer duration studies in larger population can be conducted to further confirm these findings. TRIAL REGISTRATION DETAILS: Clinical Trial Registry-India URL: http://ctri.nic.in, Registration Number: CTRI/2009/091/001036.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Hidroxicloroquina/uso terapêutico , Hipoglicemiantes/uso terapêutico , Tiazolidinedionas/uso terapêutico , Adolescente , Adulto , Idoso , Biomarcadores/sangue , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/sangue , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Gliclazida/uso terapêutico , Hemoglobinas Glicadas/metabolismo , Humanos , Masculino , Metformina/uso terapêutico , Pessoa de Meia-Idade , Pioglitazona , Compostos de Sulfonilureia/uso terapêutico , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...